Clinical Trial Seeking Participants
eIRB study # 10103 (PI: Jeffrey Jensen, MD, MPH)
The Women’s Health Research Unit is conducting a study looking at contraceptive effects on fallopian tubes.
- Open to Enrollment
Why is this study being done?
Female permanent contraception, or sterilization, is widely used and very effective. However, it is the only method of contraception that requires surgery. The development of a non-surgical method of permanent contraception will help women avoid surgery and give them another contraceptive choice. The purpose of this study is to learn about how menstrual cycles and hormonal contraceptives affect tubal patency. Normally there is an opening between the tube and uterus to permit the flow of fluid and cells. If this opening is blocked, this can result in infertility. Tubal patency is when a woman's fallopian tubes are not blocked. Tubal patency is determined by hysteron-(uterus)salpingo-(fallopian tube)graphy (HSG), an X-ray test. This study requires up to 3-5 studies and will take approximately 6 months to complete.
Who is eligible to participate?Women who are between the ages of 18 and 40 who:
- Have normal menstrual cycles that occur every 24-37 days
- Are in good health
- Are not currently using hormonal contraception or an intrauterine device OR have had at least one complete menstrual cycle since stopping hormonal contraception or an intrauterine device
- Have not undergone bilateral tubal ligation or tubal surgery
- Are willing to take hormonal contraception as part of study participation
What is the compensation for this study?
Eligible female subjects who complete the study will receive a maximum of $1,160 compensation for their participation.